Prostate Cancer: Axumin/PSMA Pet CT and Pluvicto therapy
Christopher Maney RN, BSN, OCN
The one hour presentation will describe the use of both conventional and new radiopharmaceutical agents and indications for prostate cancer.
Healthcare employees working in radiation oncology or caring for patients being treated by radiation oncology departments
Discuss the use/limitations of conventional diagnostics in biochemical recurrence of prostate cancer
Understand developments in prostate specific PET CT imaging (PSMA and Axumin)
Recall indications for prostate specific PET CT imaging
Identify radiopharmaceutical agents and indications for use
Susan D'Arcangelo RTT
Dana Diehl BSN, RN, OCN
Jamie Kruger RT
Kellie Ritchey BSN, RN
Apryl Spencer BSN, RN, OCN
Amy Wiley BSN, RN
In support of improving patient care, the University of Pittsburgh is jointly accredited by the
Accreditation Council for Continuing Medical Education (ACCME), the Accreditation
Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center
(ANCC), to provide continuing education for the healthcare team.
The maximum number of hours awarded for this Continuing Nursing Education activity is
1 contact hour.
1. To receive credit the learner must attend the course via Teams attendance and sign virtually into the activity.
2. The learner must complete the course evaluation on the CCE website
3. Once steps one and two are complete, the learner may claim credit on the CCEHS Learning Portal.
- 1.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 1.00 Attendance